PBM
MBB icon

Propel Bio Management’s iShares MBS ETF MBB Stock Holding History

Propel Bio Management’s Portfolio MBB Stock Details MBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-22,400
Closed -$2.07M – 28
2024
Q1 		$2.07M Hold
22,400
– – 1.21% 16
2023
Q4 		$2.11M Buy
+22,400
New +$2.01M 1.75% 17

Other funds holding MBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
TIAA Trust, National Association
TIAA Trust, National Association Charlotte, North Carolina $1.69B AUM 19.12% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Propel Bio Management's MBB Position: Q2 2024 in Review

Propel Bio Management sold out of iShares MBS ETF (MBB) in Q2 2024, closing a stake of 22,400 shares — an estimated $2.07M sold.

Propel Bio Management first reported a position in MBB in Q4 2023 and held it in 2 quarters. The position peaked at $2.11M in Q4 2023. 836 funds tracked by Wall St. Rank hold MBB as of Q2 2024.

  • Propel Bio Management reported no remaining iShares MBS ETF position as of Q2 2024 after selling out during the quarter.
  • Propel Bio Management sold 22,400 iShares MBS ETF shares in Q2 2024, an estimated $2.07M.
  • Propel Bio Management first reported a position in iShares MBS ETF in Q4 2023 and held it in 2 quarters.
  • Propel Bio Management's iShares MBS ETF position peaked at $2.11M in Q4 2023.
  • 836 funds tracked by Wall St. Rank held iShares MBS ETF as of Q2 2024.

Based on Propel Bio Management's 13F filing for Q2 2024, filed 12 Aug 2024.